In the mutational analysis, we found that only 5.7% (9/156) breast cancer cases have somatic mutations in exon 2 and exon 4 of Parkin gene (Fig. 2d & e), the same were absent in the normal adjacent tissues. This evidence concerns the gene PRKN and breast carcinoma.